Omeros Correlations

OMER Stock  USD 8.62  0.22  2.49%   
The current 90-days correlation between Omeros and Oric Pharmaceuticals is -0.07 (i.e., Good diversification). The correlation of Omeros is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Omeros Correlation With Market

Average diversification

The correlation between Omeros and DJI is 0.17 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Omeros and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omeros. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
To learn how to invest in Omeros Stock, please use our How to Invest in Omeros guide.

Moving against Omeros Stock

  0.8GNFT GenfitPairCorr
  0.76VALN Valneva SE ADR Upward RallyPairCorr
  0.73UPC Universe PharmaceuticalsPairCorr
  0.69ME 23Andme HoldingPairCorr
  0.62XWEL XWELL IncPairCorr
  0.57JNJ Johnson JohnsonPairCorr
  0.52HCM HUTCHMED DRCPairCorr
  0.51OCEAW Ocean BiomedicalPairCorr
  0.42PFE Pfizer Inc Earnings Call This WeekPairCorr
  0.38LLY Eli Lilly Earnings Call This WeekPairCorr
  0.76AMGN Amgen Inc Earnings Call This WeekPairCorr
  0.74SHPH Shuttle PharmaceuticalsPairCorr
  0.69ABOS Acumen PharmaceuticalsPairCorr
  0.68PRPH ProPhase LabsPairCorr
  0.67REGN Regeneron PharmaceuticalsPairCorr
  0.6APGE Apogee Therapeutics,PairCorr
  0.56AQST Aquestive TherapeuticsPairCorr
  0.49ABBV AbbVie Inc Buyout TrendPairCorr
  0.7SYRE Spyre TherapeuticsPairCorr
  0.63TTOO T2 BiosystmsPairCorr
  0.63ENSG Ensign GroupPairCorr
  0.62AVDL Avadel PharmaceuticalsPairCorr
  0.5TCRX Tscan TherapeuticsPairCorr
  0.42TOVX Theriva BiologicsPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
LYELENTA
FOLDENTA
ENTACRNX
LYELCRNX
DSGNCRNX
LYELFOLD
  
High negative correlations   
DSGNORIC
LGNDCNTB
ORICCRNX
ORICCNTB
ORICCERE
LGNDCERE

Risk-Adjusted Indicators

There is a big difference between Omeros Stock performing well and Omeros Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Omeros' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
CRNX  2.34 (0.62) 0.00 (0.47) 0.00 
 3.10 
 21.52 
ENTA  2.77 (1.31) 0.00 (1.15) 0.00 
 6.95 
 30.73 
FOLD  1.37 (0.36) 0.00 (0.38) 0.00 
 2.33 
 11.40 
CERE  0.77  0.07 (0.01) 12.08  0.94 
 1.91 
 6.40 
CNTB  3.87 (0.13) 0.00  0.21  0.00 
 8.66 
 29.84 
LGND  2.19  0.07  0.01  0.19  3.22 
 4.64 
 17.92 
PASG  6.88  0.46  0.04 (1.44) 6.85 
 20.97 
 84.39 
ORIC  3.71  0.34  0.08  0.31  4.22 
 8.04 
 22.87 
LYEL  4.65 (0.83) 0.00 (0.90) 0.00 
 11.63 
 36.92 
DSGN  4.39 (0.06) 0.00 (0.13) 0.00 
 8.72 
 33.11 

Omeros Corporate Management

Peter JDGeneral VPProfile
Nadia DacVP OfficerProfile
Debra MTChief OfficerProfile
David GhesquiereChief OfficerProfile
Andreas MDChief OfficerProfile
Gregory MDChairman, CoFounderProfile